Adverse events12

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 12 of 12

Type	Event	Organ system	Group	Affected	At risk	Events
other	Insomnia	Nervous system disorders	Dalfampridine	4	12	4
other	Insomnia	Nervous system disorders	Placebo	0	12	0
other	Nausea	Gastrointestinal disorders	Dalfampridine	5	12	5
other	Nausea	Gastrointestinal disorders	Placebo	0	12	0
other	Muscle weakness	Musculoskeletal and connective tissue disorders	Dalfampridine	2	12	2
other	Muscle weakness	Musculoskeletal and connective tissue disorders	Placebo	6	12	6
other	Balance problems	Musculoskeletal and connective tissue disorders	Dalfampridine	2	12	2
other	Balance problems	Musculoskeletal and connective tissue disorders	Placebo	4	12	4
other	Dizziness	Nervous system disorders	Dalfampridine	3	12	3
other	Dizziness	Nervous system disorders	Placebo	0	12	0
other	Itching/skin reactions	Skin and subcutaneous tissue disorders	Dalfampridine	1	12	1
other	Itching/skin reactions	Skin and subcutaneous tissue disorders	Placebo	1	12	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01444300/events